Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04996849 · ClinicalTrials.gov registry record
Contemporary Characteristics of Penile Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 499
- Enrollment target
NCT04996849: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT04996849 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 499 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04996849 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 499 participants
- Enrollment target
Study Summary
This study develops a prospective database of patients who are evaluated and treated for penile cancer. This will facilitate analyzing trends in cancer incidence, risk factors, treatment, complications, and tumor progression. It will also prospectively validate the importance of pathological prognostic factors previously reported and outcome related to contemporary treatment.
Interventions
- OTHER Questionnaire Administration
- OTHER Data Capture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2004-04-22 |
| Est. Completion | 2025-09-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04996849
The ClinicalTrials.gov registry entry for NCT04996849 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 499 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT04996849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04996849 about?
NCT04996849 is a clinical study titled "Contemporary Characteristics of Penile Cancer". This study develops a prospective database of patients who are evaluated and treated for penile cancer. This will facilitate analyzing trends in cancer incidence, risk factors, treatment, complications, and tumor progression. It will also prospectively validate the importance of pathological prognos...
What is the current status of trial NCT04996849?
This trial is currently terminated. The enrollment target is 499 participants. The study started on 2004-04-22. Estimated completion is 2025-09-17.
What interventions are being tested in trial NCT04996849?
The interventions under investigation include: Questionnaire Administration (OTHER), Data Capture (OTHER).
Who is sponsoring clinical trial NCT04996849?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.